Лучевая терапия в лечении незлокачественных заболеваний
Автор: Щербенко О.И.
Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr
Рубрика: Обзоры, лекции
Статья в выпуске: 2 т.22, 2022 года.
Бесплатный доступ
Опыт применения ионизирующего излучения при незлокачественной патологии насчитывает уже более 100 лет. В начале и середине прошлого века лучевая терапия широко применялась при многих воспалительных, эндокринных, кожных, пролиферативных, дегенеративных заболеваниях. Успехи фармакологии и хирургии, а также распространяющаяся среди врачей и населения радиофобия сократили сферу применения метода. Однако растущая стоимость лекарственной терапии, осложнения, связанные с ее использованием, достижение пределов хирургических возможностей, делают целесообразным обращение к ретроспективному рассмотрению опыта использования ионизирующего излучения для лечения незлокачественных заболеваний и возможному его ребрендингу. В сравнении с существующими методами лечения при ряде заболеваний лучевая терапия обладает преимуществами в виде более высокой экономической и клинической эффективности, сравнительной простоты и доступности. Проведенный анализ имеющейся в литературе информации показывает, что при ряде кожных, пролиферативных, обменно-дистрофических,инфекционных заболеваний лучевая терапия может и должна применяться при надлежащем соблюдении показаний и противопоказаний.
Ионизирующее излучение, лучевая терапия, доброкачественные опухоли, воспалительные заболевания, мальформации
Короткий адрес: https://sciup.org/149141310
IDR: 149141310
Radiation therapy in the treatment of non-malignant diseases
Experience in the use of ionizing radiation in non-malignant pathology has more than 100 years. At the beginning and middle of the last century, radiation therapy was widely used for many inflammatory, endocrine, skin, proliferative, and degenerative diseases. Advances in pharmacology and surgery, as well as radiophobia spreading among doctors and the public, have reduced the scope of the method. However, the growing cost of drug therapy, the complications associated with its use, the achievement of the limits of surgical possibilities, make it appropriate to address the retrospective review of the experience of using ionizing radiation for the treatment of non- malignant diseases and its possible rebranding. In comparison with existing methods of treatment for a number of diseases, radiation therapy has the advantages of higher economic and clinical efficiency, comparative simplicity and accessibility. The analysis of the information available in the literature shows that for a number of skin, proliferative, metabolic-dystrophic, and infectiousdiseases, radiation therapy can and should be used with proper observance of indications and contraindications.
Список литературы Лучевая терапия в лечении незлокачественных заболеваний
- Rödel F., Keilholz L., Herrmann M., et al. Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy. Int J Radiat Biol. 2007. V. 83. No. 6. P. 357-366. DOI: 10.1080/09553000701317358.
- Roedel F., Kley N., Beuscher H.U., et al. Anti-inflammatory effect of low-dose X-irradiation and the involvement of a TGF-beta1-induced down-regulation of leukocyte/endothelial cell adhesion. Int J Radiat Biol. 2002. V. 78. No. 8. P. 711-719. DOI: 10.1080/09553000210137671.
- Brown W.M., Doll R. Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med J. 1965. V. 2. No. 5474. P. 1327-1332. Doi:10.1136/bmj.2.5474.1327.
- McKeown S.R, Hatfield P., Prestwich R., et al. Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation. Br J Radiol. 2015. V. 88. No. 1056. Article ID 20150405. DOI: 10.1259/bjr.20150405.
- Rödel F., Fournie C., Wiedemann J., et al. Basics of Radiation Biology When Treating Hyperproliferative Benign Diseases. Front Immunol. 2017. V. 8. Article ID 519. DOI: 10.3389/fimmu.2017.00519.
- Rodel F., Frey B., Multhoff G., Gaipl U. Contribution of the immune system to bystander and non-targeted effects of ionizing radiation. Cancer Lett. 2015. V. 356. No. 1. P. 105-113. DOI: 10.1016/j.canlet.2013.09.015.
- Kleis W., Pico G. Thio-TEPA therapy to present post operative pterygium occurrence and neovascularization. Am J Ophthalmol. 1973. V. 76. No. 3. P. 371-373. DOI: 10.1016/0002-9394(73)90493-5.
- Lentino W., ZaretM.M., Rossignol B., RubenfeldS. Treatment of pterygium by surgery followed by beta radiation: an analysis of 256 cases. Am J Roentgenol Radium Ther Nucl Med. 1959. V. 81. No. 1. P. 93-98.
- van den Brenk H.A.S. Results of prophylactic postoperative irradiation in 1300 cases of pterygium. Am J Roentgenol. 1968. V. 103. P. 723-733.
- Frau E., Rumen F., Noel G., et al. Low-dose proton beam therapy for circumscribed choroidal hemangiomas. Arch Ophthalmol. 2004. V. 122. No. 10. P. 1471-1475. DOI: 10.1001/archopht.122.10.1471.
- Levy-Gabriel C., Lumbroso-Le Rouic L., Plancher C., et al. Long-term results of low-dose proton beam therapy for circumscribed choroidal hemangiomas. Retina. 2009. V. 29. No. 2. P. 170175. DOI: 10.1097/IAE. 0b013e31818bccfb.
- Evans J.R., Sivagnanavel V., Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2010. V. 2010. No. 5. Article ID CD004004. DOI: 10.1002/14651858.CD004004.
- Ye§ilta§ Y.S., Gunduz A.K. Idiopathic Orbital Inflammation: Review of Literature and New Advances. Middle East Afr J Ophthalmol. 2018. V. 25. No. 2. P. 71-80. DOI: 10.4103/meajo.MEAJO_44_18.
- Bartalena L., Baldeschi L., Dickinson A.J., et al. Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid. 2008. V. 18. P. 333-346. DOI: 10.1089/thy.2007.0315.
- TandaM.L., BartalenaL. Efficacy and safety of orbital radiotherapy for graves' orbitopathy. J Clin Endocrinol Metab. 2012. V. 97. No. 11. P. 3857-3865. DOI: 10.1210/jc.2012-2758.
- Healy W.L., CovallD.J., Dotter W.E., et al. Heterotopic bone formation after hip surgery: prevention with single-dose postoperative hip irradiation. Radiology. 1988. V. 168. No. 3. P. 851854. DOI: 10.1148/radiology.168.3.3136510.
- HeydR., Tselis N., Ackermann H., et al. Radiation therapy for painful heel spurs: results of a prospective randomized study. Strahlenther Onkol. 2007. V. 183. No. 1. P. 3-9. DOI: 10.1007/s00066-007-1589-1.
- NiewaldM., SeegenschmiedtM.H., Micke O., Gräber S.; German Cooperative Group on the Radiotherapy for Benign Diseases of the DEGRO German Society for Radiation Oncology. Randomized multicenter trial on the effect of radiotherapy for plantar Fasciitis (painful heel spur) using very low doses--a study protocol. Radiat Oncol. 2008. V. 3. Article ID 27. DOI: 10.1186/1748-717X-3-27.
- Tsagozis P., Brosjö O. Current Strategies for the Treatment of Aneurysmal Bone Cysts. Orthop Rev (Pavia). 2015. V. 7. No. 4. Article ID 6182. DOI:10.4081/or.2015.6182.
- Heyd R., Seegenschmiedt M.H., Rades D., et al. German Cooperative Group on Radiotherapy for Benign Diseases. Radiotherapy for symptomatic vertebral hemangiomas: results of a multicenter study and literature review. Int J Radiat Oncol Biol Phys. 2010. V. 77. No. 1. P. 217-225. DOI: 10.1016/j.ijrobp.2009.04.055.
- Ragoowansi R, Cornes P.G., Glees J.P., et al. Ear-lobe keloids: treatment by a protocol of surgical excision and immediate postoperative adjuvant radiotherapy. Br J Plast Surg. 2001. V. 54. No. 6. P. 504-508. DOI: 10.1054/bjps.2001.3656.
- Seegenschmiedt M.H., Olschewski T., Guntrum F. Radiotherapy optimization in early-stage Dupuytren's contracture: first results of a randomized clinical study. Int J Radiat Oncol Biol Phys. 2001. V. 49. No. 3. P. 785-798. DOI: 10.1016/S0360-3016(00)00745-8.
- de Haan A., van Nes J.G., Werker P.M.N., et al. Radiotherapy for patients with Ledderhose disease: Long-term effects, side effects and patient-rated outcome. Radiother Oncol. 2022. V. 168. P. 83-88. DOI: 10.1016/j.radonc.2022.01.031.
- O'Sullivan B., Cummings B., Catton C., et al. Outcome following radiation treatment for high-risk pigmented villonodular synovitis. Int J Radiat Oncol Biol Phys. 1995. V. 32. P. 777-786.
- Pietsch G., Anzeneder T., Bruckbauer H., et al. Superficial radiation therapy in peyronie's disease: An effective and well-tolerated therapy. Adv Radiat Oncol. 2018. V. 3. No. 4. P. 548-551. DOI: 10.1016/j.adro.2018.07.009.
- Sumila M., Notter M., Itin P., et al. Long-term results of radiotherapy in patients with chronic palmo-plantar eczema or psoriasis. Strahlenther Onkol. 2008. V. 184. No. 4. P. 218-223. DOI: 10.1007/s00066-008-1788-4.
- Hendrickx A., Cozzio A., Plasswilm L., Cédric M. Radiotherapy for lentigo maligna and lentigo maligna melanoma - a systematic review. Radiat Oncol. 2020. V. 15. No. 1. Article ID 174. DOI: 10.1186/s13014-020-01615-2.
- de Vries A.C., Bogaards N.A., Hooft L., et al. Interventions for nail psoriasis. Cochrane Database Syst Rev. 2013. V. 1. Article ID CD007633. DOI: 10.1002/14651858.CD007633.pub2.
- Rashid A., Pintea B., Kinfe T.M., et al. LINAC stereotactic radiosurgery for trigeminal neuralgia - retrospective two-institutional examination of treatment outcomes. Radiat Oncol. 2018. V. 13. No. 1. Article ID 153. DOI: 10.1186/s13014-018-1102-2.
- Day S.E., Halasz L.M. Radiation therapy for WHO grade I meningioma. Chin Clin Oncol. 2017. V. 6. (Suppl. 1). P. S4. DOI: 10.21037/cco.2017.06.01.
- Punyawai P., Radomsutthikul N., Dhanachai M., et al. Long-term outcomes of 170 brain arteriovenous malformations treated by frameless image-guided robotic stereotactic radiosurgery Medicine (Baltimore). 2021. V. 100. No. 19. Article ID e25752. DOI: 10.1097/MD.0000000000025752.
- Persson O., Bartek J. Jr., Shalom N.B., et al. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review. Acta Neurochir (Wien). 2017. V. 159. No. 6. P. 1013-1021. DOI: 10.1007/s00701-017-3164-6.
- Assouline A., Levy A., Abdelnour-Mallet M., et al. Radiation therapy for hypersalivation: a prospective study in 50 amyotrophic lateral sclerosis patients. Int J Radiat Oncol Biol Phys. 2014. V. 88. No. 3. P. 589-595. DOI: 10.1016/j.ijrobp.2013.11.230.
- Mendenhall W.M., Mendenhall C.M., Werning J.W., et al. Salivary gland pleomorphic adenoma. Am J Clin Oncol. 2008. V. 31. No. 1. P. 95 Article ID 99. DOI: 10.1097/COC.0b013e3181595ae0.
- Mendenhall W.M., Amdur R.J., VaysbergM., et al. Head and neck paragangliomas. Head Neck. 2011. V. 33. No. 10. P. 1530-1534. DOI: 10.1002/hed.21524.
- Frohlich D., Baaske D., GlatzelM. Radiotherapy of hidradenitis suppurativa—still valid today? [In German.] Strahlenther Onkol. 2000. V. 176. No. 6. P. 286-289.
- Viani G.A., Bernardes da Silva L.G., Stefano E.J. Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy? Int J Radiat Oncol Biol Phys. 2012. V. 83. No. 4. P. e519-524. DOI: 10.1016/j.ijrobp.2012.01.036.
- Calabrese E.J., Dhawan G. How Radiotherapy Was Historically Used to Treat Pneumonia: Could It Be Useful Today? Yale J Biol Med. 2013. V. 86. No. 4. P. 555-570.
- Gupta S., Ahuja R., Sharma N., et al. Low dose lung radiotherapy for COVID-19 pneumonia: A potential treatment. Respir Med. 2021. V. 186. Article ID 106531. DOI: 10.1016/j.rmed.2021.106531.
- Ott O.J., Hertel S., Gaipl S., et al. The Erlangen Dose Optimization Trial for radiotherapy of benign painful shoulder syndrome. Long-term results. Strahlenther Onkol. 2014. V. 190. No. 4. P. 394-398. DOI: 10.1007/s00066-013-0520-1.
